FDA - Spark Newswire

1 minute read

Eton Pharma Stock Is Trading Higher After FDA Approval For Rezipres

Today, 2:01 AM

The FDA has approved Eton Pharmaceuticals Inc’s (NASDAQ:ETON) Rezipres (ephedrine hydrochloride injection) to treat clinically significant hypotension occurring in the setting…

ETON

1 minute read

VBL Therapeutics Shares Drop As Pending Clearance Of New Batches Cancer Gene Therapy Hit Recruitment In Ovarian Cancer Trial

By Vandana Singh

Today, 2:01 AM

The FDA notified VBL Therapeutics Ltd (NASDAQ: VBLT) that clearance of new VB-111 batches for use in the U.S. is currently pending, as review by the Chemistry, Manufacturing, and Controls (CMC) group is still ongoing.

VBLT

1 minute read

FDA
News

Eton Pharmaceuticals Announces FDA Approval Of Rezipres (Ephedrine Hydrochloride Injection); Shares Set To Resume Trade At 11:10 a.m. EDT

By Benzinga Newsdesk

Today, 2:01 AM

Eton Pharmaceuticals, Inc (NASDAQ:ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres® (ephedrine hydrochloride injection) for the treatment of clinically important

ETON

2 minute read

FDA
News

Synlogic Says Presents Additional Preclincal Data On Therapeutic Candidates SYNB1934 For Phenylketonuria And SYNB8802 For Enteric Hyperoxaluria At Synthetic Biology: Engineering, Evolution & Design Conference

By Benzinga Newsdesk

Today, 2:01 AM

Synlogic, Inc. (NASDAQ:SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today presented on the development of the investigational Synthetic Biotic

SYBX

1 minute read

NIH Says Study Offers New Evidence Of Early COVID-19 Infections In U.S.

By Benzinga Newsdesk

Today, 2:01 AM

-Reuters

SPY

1 minute read

Axsome Therapeutics Targets Submission Of US Application For Fibromyalgia Candidate By 2022

By Vandana Singh

Today, 2:01 AM

After a pre-NDA meeting with FDA, Axsome Therapeutics Inc (NASDAQ:AXSM) has announced its plan to submit a marketing application seeking approval for…

AXSM

1 minute read

FDA
News

Synlogic Shares Quiet; Traders Circulate Co’s Poster Presentations Titled ‘Development of a Synthetic Biotic’ And ‘Synthetic Biology Approaches for the Optimization and Improvement of a Live Bacterial Therapeutic’

By Benzinga Newsdesk

Today, 2:01 AM

https://investor.synlogictx.com/index.php/static-files/5597a995-f485-431e-b9a0-2541a78c6614 https://investor.synlogictx.com/index.php/static-files/67b4fe9d-d797-421d-b44b-4ed8fcd44b5f

SYBX

2 minute read

FDA
News

Seraph Research Institute Highlights Will Move Forward With First Stage Of Approval Process For HIV Candidate; Press Release Notes Proprietary Technology For Pre-Investigational New Drug Meeting Licensed To Enochian BioSciences

By Benzinga Newsdesk

Today, 2:01 AM

(NASDAQ:ENOB) – A promising cure for HIV is moving one step closer to FDA approval. The novel approach to treating HIV in humans using cell therapy, developed by Dr. Serhat Gumrukcu (Dr. Serhat), Director of

ENOB

2 minute read

Actinium Pharmaceuticals Says Safety Data Highlighting Low Rates Of Adverse Events And Non-Relapse Transplant Related Mortality In Patients Receiving Lomab-B Presented At 2021 SNMMI Virtual Conference

By Benzinga Newsdesk

Today, 2:01 AM

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) ("Actinium") today highlighted safety data from its ongoing pivotal Phase 3 SIERRA trial of Iomab-B in patients with relapsed or refractory Acute Myeloid

ATNM

2 minute read

ImmunoPrecise Antibodies Says Preclinical Data From Co’s Drug Pipeline To Be Presented During BIO International Partnering Event From June 14-18

By Benzinga Newsdesk

Today, 2:01 AM

IMMUNOPRECISE ANTIBODIES LTD (the "Company" or "IPA") (NASDAQ:IPA) (TSXV:IPA) today announced the results from in vitro characterizations investigating TATX-21, a novel potential

IPA